The largest database of trusted experimental protocols

Dneasy blood and tissue mini kit

Manufactured by Qiagen
Sourced in Germany, Spain

The DNeasy Blood and Tissue Mini Kit is a product from Qiagen designed for the extraction and purification of DNA from a variety of biological samples, including blood, tissue, and cultured cells. The kit utilizes a spin-column based method to efficiently capture and purify DNA, which can then be used in various downstream applications.

Automatically generated - may contain errors

41 protocols using dneasy blood and tissue mini kit

1

Mitochondrial DNA Analysis in Microglia

Check if the same lab product or an alternative is used in the 5 most similar protocols
For whole-cell mtDNA analysis, control and ddC-treated BV2 cells were collected on day 6. Total DNA was purified using the DNeasy Blood and Tissue Mini Kit (Qiagen, 69504) according to the manufacturer’s instructions. For analysis of the cytosolic fraction in BV2 cells, DNA was isolated from either control or irradiated cells (wild-type and ρ0, collected on day 6 after irradiation) using the Mitochondria/Cytosol Fractionation Kit (BioVision, K256) according to the manufacturer’s instructions. For the analysis in young and aged mouse primary microglia, cells were fractionated using digitonin isolation buffer (150 mM NaCl, 50 mM HEPES, 25 μg ml−1 digitonin) for 10 min on ice, then centrifuged at 2,000g for 5 min to separate cytosolic and membranous extracts. DNA was isolated from all fractions using the DNeasy Blood and Tissue Mini Kit (Qiagen, 69504) according to the manufacturer’s instructions. Isolated DNA (diluted to 20 ng ml−1) was used as a template for qPCR analysis of mitochondrial DNA sequences Mito and CoI expression, using B2m as a nuclear control.
+ Open protocol
+ Expand
2

Optimal Cutting Temperature Removal

Check if the same lab product or an alternative is used in the 5 most similar protocols
A pretreatment was carried out to eliminate the Optimal Cutting Temperature medium that was used to embed the samples. This process consisted of adding 1 ml of phosphate-buffered saline to the samples on dry ice, followed by centrifugation for 15 min at 1,000 g force removal of the supernatant, and addition of 180 μl of ATL Buffer (Tissue Lysis Buffer). After homogenization of the mixture, 20 μl of proteinase K was added. Finally, the samples were incubated at 56°C for 24 h with shaking, for their full digestion. For DNA extraction, DNeasy Blood and Tissue Mini Kits (Qiagen) were used according to the manufacturer’s instructions. Purified nucleic acids were quantified using a QuantiFluor® dsDNA System fluorometer and stored at –80°C.
+ Open protocol
+ Expand
3

Isolation and Cultivation of Primary Blood Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Buffy coats were collected from volunteer blood donors at the New York Blood Center (http://nybloodcenter.org/). These samples were obtained anonymously; therefore, the MSKCC IRB waived the need for additional research consent. Peripheral blood was additionally collected from healthy donors at MSKCC following approval by the MSKCC IRB, and donors provided informed written consent. PBMC were isolated by ficoll purification, aliquoted and stored in liquid nitrogen prior to experimentation. DNA was isolated from PBMCs using DNeasy Blood and Tissue mini kits (Qiagen, Valencia, CA).
Expi293F cells were maintained in Expi293 expression medium according to the manufacturer’s instructions (Life Technologies, Grand Island, NY). Phoenix A cells were obtained from ATCC and maintained in DMEM containing 10% FBS. 721.221 and Jurkat cells, kind gifts from Dr. Richard O’Reilly (Memorial Sloan Kettering Cancer Center) and Dr. Steven Nimer (University of Miami, Miami FL), respectively, were maintained in RPMI containing 10% FBS.
+ Open protocol
+ Expand
4

Whole Genome Sequencing of Bacterial Isolates

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genomic DNA was extracted with the DNeasy Blood and Tissue Mini Kit (QIAGEN, Germany) or DNeasy UltraClean Microbial Kit (QIAGEN, Germany) for Illumina and Nanopore sequencing, respectively. WGS was performed at the Microbial Genomics Reference Laboratory, NSW Health Pathology. All strains were short-read sequenced on the NextSeq platform (Illumina, USA). In addition, strains CIDM-BP2, CIDM-BP3, CIDM-BH3, CIDM-BPP2 and CIDM-BPP2R were also long-read sequenced on the MinION platform (Oxford Nanopore Technologies plc, UK). Sequencing libraries for Illumina sequencing were prepared using the Nextera XT DNA Library Prep Kit (Illumina) and sequenced on a NextSeq 500 using NextSeq 500/550 v2 mid output kits (Illumina). Sequencing libraries for Nanopore sequencing were prepared using the Rapid Barcoding kit (SQK-RBK004) and sequencing on a R9 flowcell. Total RNA was extracted from liquid cultures using the RNeasy Plus Universal Mini Kit (QIAGEN, Germany), following manufacturer’s protocol. Total RNA sequencing was performed by the Australian Genomics Research Facility (AGRF) utilizing the Illumina Stranded Total RNA Prep with Ribo-Zero Plus on the NovaSeq.
+ Open protocol
+ Expand
5

Targeted Exome Sequencing of Tumor and Normal

Check if the same lab product or an alternative is used in the 5 most similar protocols
Samples were prepared, sequenced and analyzed as described earlier (Bertotti et al., 2015 (link)). DNA was extracted from cells and xenograft tissues using the Qiagen DNeasy blood and tissue mini kit (Qiagen, CA). Fragmented genomic DNA from tumor and normal samples was used for Illumina TruSeq library construction (Illumina, San Diego, CA). Exonic regions or targeted regions (targeted genes-Table S3) were captured in solution using the Agilent SureSelect v.4 kit (Agilent, Santa Clara, CA) according to the manufacturer’s instructions as previously described (Bertotti et al., 2015 (link); Sausen et al., 2013 (link)). Paired-end sequencing, resulting in 100 or 150 bases from each end of the DNA fragments for the exome or targeted sequencing libraries, respectively, was performed using Illumina HiSeq 2000/2500 instrumentation (Illumina, San Diego, CA).
+ Open protocol
+ Expand
6

Selecting HIV-1 Drug Resistance Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
Selection of HIV-1 variants resistant to ARVs was performed by serial passaging of NL4-3 in the SupT1 (NL4-3 and derivatives) or SupT1huR5 [NL(AD8) and CH185] T cell lines with increasing concentrations of DTG or EFdA. The culture supernatant was harvested on day 7 and used to infect fresh cells for the next round of culture in the presence of the same or increasing concentrations of the compounds. Dose escalation was performed when a cytopathic effect was observed. At the indicated time points, genomic DNA was extracted from infected cells using the DNeasy Blood and Tissue Minikit (Qiagen), and the Gag-, Pol-, Env-, and Nef-coding regions were amplified by PrimeSTAR GXL DNA polymerase (Takara Bio) and sequenced (Psomagen or Poochon Scientific) using previously described primers (77 (link), 78 (link)).
+ Open protocol
+ Expand
7

Bacterial Genome Sequencing and Annotation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genomic DNA was extracted from overnight bacterial culture using the DNeasy Blood and Tissue Mini kit (QIAGEN GmbH, Germany). Standard genomic library was prepared from the bacterial DNA and sequenced with the Illumina MiSeq platform (2 × 300 bp paired end), as described elsewhere (Klein et al., 2020 ). For quality control, raw sequences were trimmed using Sickle 1.33 (parameters, q > 30; 1 > 45). Obtained contigs were curated for length (>1000 bp) and coverage (>10×). Sequences are available under the BioProject-Numbers PRJNA561696 and PRJNA637212. Sequences were annotated using Prokka 1.14.1 (Seemann, 2014 (link)) (based on Genetic Code Table 11). Resistance genes were found using Abricate 0.8.13 with the databases from ResFinder, NCBI, CARD, ARG-ANNOT (Zankari et al., 2012 (link); Gupta et al., 2014 (link); Jia et al., 2017 (link); Feldgarden et al., 2019 (link)), to identify potential variants in the DHFR genes. For the DHPS gene, the region of interest was extracted from the assembly with Samtools (Etherington et al., 2015 (link)) and aligned with MAFFT (Nakamura et al., 2018 (link)). Unique representative sequences were obtained with CD-Hit (Li and Godzik, 2006 (link)) (100% identity) and SNPs were then called with snp-sites (Page et al., 2016 ).
+ Open protocol
+ Expand
8

Nucleic Acid Extraction from Frozen Tissue

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tissue samples were frozen in liquid nitrogen and stored at -80°C post resection, and subsequently transferred to RNAlater ICE (Qiagen) and stored at -20°C. As described previously [23 (link)], nucleic acid extraction was performed on < 20mg of tissue by a single operator in one batch to avoid variation in protocol. Tissue disruption was carried out using a Retch Mixer mill. DNeasy Blood and Tissue Mini Kit (Qiagen) and RNEasy Plus Mini Kit (Qiagen) were used for DNA and RNA extraction, respectively. Quantification of the extracted nucleic acids was carried out using a NanoDrop 2000c spectrophotometer (Thermo Scientific, Asheville, NC, USA) and samples were stored at -80°C.
+ Open protocol
+ Expand
9

Bacterial Genome Sequencing and Annotation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genomic DNA was extracted from overnight bacterial culture using the DNeasy Blood and Tissue Minikit (Qiagen GmbH, Hilden, Germany). Standard genomic library was prepared from the bacterial DNA and sequenced with the Illumina MiSeq platform (2 × 300 bp paired end), as described elsewhere [34 (link)]. For quality control, raw sequences were trimmed using Sickle 1.33 (parameters, q  >  30; 1  >  45). Clean reads were assembled with spades 3.13 with the option –careful and –only-assembler [35 (link)]. Obtained contigs were curated for length (>1000 bp) and coverage (>10×). Sequence was annotated using Prokka 1.14.1 (based on Genetic Code Table 11). Resistance genes were found using Abricate 0.8.13. Briefly, the draft genome was mapped to the database of CARD, NCBI AMRFinderPlus, Resfinder and ARG-ANNOT [36 (link),37 (link),38 (link),39 (link)] and hits with a minimum identity of 90% and a minimum coverage of 80% were considered as AMR genes present in our draft genome. The sequence was uploaded to the NCBI database under Bioproject Accession PRJNA661395.
+ Open protocol
+ Expand
10

DNA Extraction from DCIS Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA was isolated using Qiagen (Hilden, Germany) DNeasy Blood and Tissue Mini Kit. Samples were thawed and centrifuged at 16 000g for 15 minutes to precipitate DNA. After complete removal of Trizol, 180 μL buffer ATL and 20 μL protease was added and the tubes incubated at 56°C overnight before addition of 200 μL buffer AL. Samples were mixed well by vortexing before 200 μL ethanol was added and the samples were again mixed well by vortexing. The samples were then transferred to DNeasy Mini spin columns and further processed as per the manufacturer's instructions before DNA was eluted in 100 μL buffer AE. To improve recovery of the DNA, the elution buffer was left on the columns for 5 minutes before a final centrifugation step. For quantification and quality assessment of the DNA, quantitative polymerase chain reaction (qPCR) was performed with the KAPA hgDNA Quantification and QC Kit (KAPA Biosystems, Wilmington, MA) as per the manufacturer's instructions. Isolation of DNA from pure DCIS tumors were performed using the QIAcube system with the AllPrep DNA/RNA Universal Kit (cat.no. 80224, Qiagen, Hilden, Germany) according to protocol provided by the supplier.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!